A Power-Packed Experience

Objectives:

• Gain direct perspective on the impact of a rare disease on life
• Identify the role that treatments for rare diseases can play in changing a life’s trajectory

Overview:

Cody Unser, the daughter of Indy 500 Racing legend Al Unser, Jr. has lived with transverse myelitis for most of her life. Her story, and the insights on how a rare disease creates disability, ignites us all to answer the unmet needs of rare diseases – and minimize marginalizing of populations young and old.

Objectives:

• Learn from seasoned experts who have commercialized cell, gene, and novel rare disease therapies.
• Capture best practices that can inform your strategies based on real-world experience.

Overview:

The market is becoming increasingly complex with new novel cutting-edge therapies entering every month. Learn how you can take fresh lessons in launch and apply those best practices to successful market entry moving forward.

Objectives:

• Learn about employer dynamics in healthcare benefit design related to high-cost therapy reinsurance challenges
• Understand the budgetary stressors on Medicaid related to critically manage access to cell and gene therapies

Overview:

Leaders in the hands-on experience of benefit design and budgetary management will share their insights on the underlying knowledge you need to have to effectively partner on all fronts and ensure that the appropriate patient gains access to the right treatment. Considerations include value-based contracting, carve-outs, and reinsurance factors.

Objectives:

• Learn about the complexities of patient coordination of care
• Understand payer strategies for prior authorization and utilization management

Overview:

Just looking at your drug’s formulary status with a payer is deceiving, as the important understanding is deeper within. This session will unleash the value of “quality of coverage” for payer coverage criteria – and the importance at the health system and patient level for getting it right the first time for prior authorizations.

Objectives:

• Understand vital decision making across the long-term vision of launch, supporting subsequent market access success for your product
• Learn best practices to minimize significant bumps in the commercialization process

Overview:

Gain insights from experts in Gross-to-Net, supply chain management, pricing compliance, and market access operationalizing critical success factors that will shape the framework for success.

Objectives:

• Learn the many steps that may be required for health system integration of novel therapies
• Generate a clear understanding of needs by role, timing for dialogue and delivery, and expectations of manufacturer/health system relationships

Overview:

Supporting a health system’s uptake of high-cost therapies – especially those that require inpatient or outpatient capacity to deliver – is more than a P&T formulary kit. It requires careful multidisciplinary coordination. Hear from key members across those different roles, learning the “must have” information and resources that you as the manufacturer must be prepared to deliver upon for each role.

Objectives:

• Take a hands-on approach to testing your assumptions – for payer strategy, for key pricing considerations, for stakeholder needs
• Leave the session with actionable steps that inform your successful commercialization

Overview:

This interactive session will allow for open questions and answers across the experts, and outline Critical Success Factors, key initiatives to consider, and steps and resources needed.